A faster 'protein printer' out of the UK earns new round of funding with plans to expand platform
Drug discovery, historically, has been no easy task — it’s a lengthy, cost-intensive process hungry for breakthroughs. A UK startup thinks its speedy “protein printer” could be a winner, and the company is looking to press its advantage with some new backers on board.
Nuclera, a startup developing a printer it says can churn out protein models within 24 hours, has closed a $42.5 million Series B round with plans to flesh out a larger platform with the fresh influx of cash, according to a release.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.